| 1 | Preclinical studies and transcriptome analysis in a model of Parkinson’s disease with dopaminergic ZNF746 expression | 14.1 | 9 | Citations (PDF) |
| 2 | AIMP2 accumulation in brain leads to cognitive deficits and blood secretion in Parkinson’s disease | 6.4 | 2 | Citations (PDF) |
| 3 | Dual inhibition of aminoacyl-tRNA synthetase interacting multifunctional protein-2 and α-synuclein by steroid derivative is neuroprotective in Parkinson’s model | 3.5 | 3 | Citations (PDF) |
| 4 | Identification and evaluation of midbrain specific longevity-related genes in exceptionally long-lived but healthy mice | 3.9 | 5 | Citations (PDF) |
| 5 | Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)2D3-treated Caco-2 cells | 4.3 | 9 | Citations (PDF) |
| 6 | Identification of Three Human POLH Germline Variants Defective in Complementing the UV- and Cisplatin-Sensitivity of POLH-Deficient Cells | 4.4 | 3 | Citations (PDF) |
| 7 | Exploring the Pathological Effect of Aβ42 Oligomers on Neural Networks in Primary Cortical Neuron Culture | 4.4 | 10 | Citations (PDF) |
| 8 | PARIS
undergoes liquid–liquid phase separation and poly(
ADP
‐ribose)‐mediated solidification | 5.2 | 8 | Citations (PDF) |
| 9 | Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson’s Disease | 4.4 | 4 | Citations (PDF) |
| 10 | Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease | 6.6 | 7 | Citations (PDF) |
| 11 | ATF4-activated parkin induction contributes to deferasirox-mediated cytoprotection in Parkinson’s disease | 2.2 | 7 | Citations (PDF) |
| 12 | Sensitive electrochemical biosensor combined with isothermal amplification for point-of-care COVID-19 tests | 9.6 | 104 | Citations (PDF) |
| 13 | Effects of 1α,25-Dihydroxyvitamin D3 on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach | 4.9 | 10 | Citations (PDF) |
| 14 | PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease | 12.5 | 61 | Citations (PDF) |
| 15 | Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegenerationBrain, 2021, 144, 3674-3691 | 8.4 | 24 | Citations (PDF) |
| 16 | Loss of zinc-finger protein 212 leads to Purkinje cell death and locomotive abnormalities with phospholipase D3 downregulation | 3.4 | 4 | Citations (PDF) |
| 17 | Deubiquitinase USP29 Governs MYBBP1A in the Brains of Parkinson’s Disease Patients | 2.5 | 9 | Citations (PDF) |
| 18 | Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson’s Disease via a Vitamin D Receptor-Dependent Pathway | 4.4 | 45 | Citations (PDF) |
| 19 | Differential Effects of 1α,25-Dihydroxyvitamin D3 on the Expressions and Functions of Hepatic CYP and UGT Enzymes and Its Pharmacokinetic Consequences In Vivo | 4.9 | 18 | Citations (PDF) |
| 20 | Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion | 12.5 | 28 | Citations (PDF) |
| 21 | PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency | 14.1 | 82 | Citations (PDF) |
| 22 | Novel Nasal Epithelial Cell Markers of Parkinson’s Disease Identified Using Cells Treated with α-Synuclein Preformed Fibrils | 2.5 | 8 | Citations (PDF) |
| 23 | Activation of the Akt1-CREB pathway promotes
RNF146
expression to inhibit PARP1-mediated neuronal death | 5.4 | 43 | Citations (PDF) |
| 24 | Quantitative analysis of nasal transcripts reveals potential biomarkers for Parkinson’s disease | 3.4 | 5 | Citations (PDF) |
| 25 | Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s Disease | 4.4 | 7 | Citations (PDF) |
| 26 | TTC3 contributes to TGF-β1-induced epithelial−mesenchymal transition and myofibroblast differentiation, potentially through SMURF2 ubiquitylation and degradation | 8.5 | 42 | Citations (PDF) |
| 27 | Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson’s diseaseBrain, 2019, 142, 2380-2401 | 8.4 | 69 | Citations (PDF) |
| 28 | Rhododendrin-Induced RNF146 Expression via Estrogen Receptor β Activation is Cytoprotective Against 6-OHDA-Induced Oxidative Stress | 4.4 | 12 | Citations (PDF) |
| 29 | The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain | 6.9 | 157 | Citations (PDF) |
| 30 | Cell-Based Screen Using Amyloid Mimic β23 Expression Identifies Peucedanocoumarin III as a Novel Inhibitor of α-Synuclein and Huntingtin Aggregates | 4.9 | 3 | Citations (PDF) |
| 31 | Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice | 7.5 | 96 | Citations (PDF) |
| 32 | PARIS reprograms glucose metabolism by HIF-1α induction in dopaminergic neurodegeneration | 2.1 | 22 | Citations (PDF) |
| 33 | Hypoxia regulates the level of glutamic acid decarboxylase enzymes and interrupts inhibitory synapse stability in primary cultured neurons | 3.7 | 21 | Citations (PDF) |
| 34 | Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models | 3.9 | 165 | Citations (PDF) |
| 35 | α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism | 14.1 | 185 | Citations (PDF) |
| 36 | Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease | 33.0 | 1,029 | Citations (PDF) |
| 37 | Trpm2 Ablation Accelerates Protein Aggregation by Impaired ADPR and Autophagic Clearance in the Brain | 3.7 | 17 | Citations (PDF) |
| 38 | PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival | 6.3 | 177 | Citations (PDF) |
| 39 | Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model | 3.4 | 50 | Citations (PDF) |
| 40 | VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2 | 8.5 | 26 | Citations (PDF) |
| 41 | Identification of transketolase as a target of PARIS in substantia nigra | 2.1 | 12 | Citations (PDF) |
| 42 | CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation | 4.4 | 28 | Citations (PDF) |
| 43 | Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein PathologyENeuro, 2017, 4, ENEURO.0004-17.2017 | 2.1 | 38 | Citations (PDF) |
| 44 | LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity | 2.0 | 44 | Citations (PDF) |
| 45 | Diaminodiphenyl sulfone–induced parkin ameliorates age-dependent dopaminergic neuronal loss | 3.4 | 14 | Citations (PDF) |
| 46 | Mitochondrial E3 Ubiquitin Protein Ligase 1 Mediates Cigarette Smoke–Induced Endothelial Cell Death and Dysfunction | 3.8 | 30 | Citations (PDF) |
| 47 | Activation of tyrosine kinase c-Abl contributes to α-synuclein–induced neurodegeneration | 10.6 | 173 | Citations (PDF) |
| 48 | Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine NeuronsENeuro, 2016, 3, ENEURO.0183-16.2016 | 2.1 | 97 | Citations (PDF) |
| 49 | Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration | 7.5 | 245 | Citations (PDF) |
| 50 | Poly (ADP-ribose) in the pathogenesis of Parkinson's disease | 3.0 | 49 | Citations (PDF) |
| 51 | The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease | 3.4 | 228 | Citations (PDF) |
| 52 | Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss | 17.1 | 210 | Citations (PDF) |
| 53 | Bortezomib Alleviates Experimental Pulmonary Arterial Hypertension | 3.8 | 43 | Citations (PDF) |
| 54 | Mesenchymal stem cell-conditioned media recovers lung fibroblasts from cigarette smoke-induced damage | 3.2 | 89 | Citations (PDF) |
| 55 | Systemic and Cell-Type Specific Profiling of Molecular Changes in Parkinson`s Disease | 0.0 | 0 | Citations (PDF) |
| 56 | Animal Models of Parkinson's Disease: Vertebrate Genetics | 6.6 | 106 | Citations (PDF) |
| 57 | Quantitative analysis of TRP channel genes in mouse organs | 6.9 | 99 | Citations (PDF) |
| 58 | PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease | 33.6 | 914 | Citations (PDF) |
| 59 | YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice | 2.3 | 25 | Citations (PDF) |
| 60 | Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage | 7.5 | 254 | Citations (PDF) |
| 61 | Cigarette Smoke Induces Akt Protein Degradation by the Ubiquitin-Proteasome System | 2.2 | 65 | Citations (PDF) |
| 62 | Bone marrow cells repair cigarette smoke-induced emphysema in rats | 3.2 | 125 | Citations (PDF) |
| 63 | TRPM8 mediates cold and menthol allergies associated with mast cell activation | 2.8 | 50 | Citations (PDF) |
| 64 | Rosiglitazone attenuates hypoxia‐induced pulmonary arterial hypertension in rats | 4.0 | 83 | Citations (PDF) |
| 65 | Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function | 7.5 | 275 | Citations (PDF) |
| 66 | Tet-Off Conditional Transgenic Approaches in Modeling Parkinson's Disease in Mice | 0.0 | 0 | Citations (PDF) |
| 67 | Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract | 11.3 | 49 | Citations (PDF) |
| 68 | Regulation of expression of matrix metalloproteinase-9 by JNK in Raw 264.7 cells: presence of inhibitory factor(s) suppressing MMP-9 induction in serum and conditioned media | 11.3 | 44 | Citations (PDF) |
| 69 | Mitochondrial Biology in Parkinson's Disease | 0.0 | 1 | Citations (PDF) |
| 70 | SP600125, a selective JNK inhibitor, aggravates hepatic ischemia-reperfusion injury | 11.3 | 34 | Citations (PDF) |
| 71 | Simvastatin Inhibits Cigarette Smoking–induced Emphysema and Pulmonary Hypertension in Rat Lungs | 8.9 | 241 | Citations (PDF) |
| 72 | Painful Channels in Sensory Neurons | 4.9 | 86 | Citations (PDF) |
| 73 | Expression of hOGG1 protein during differentiation of HL-60 cells | 11.3 | 3 | Citations (PDF) |
| 74 | Base excision repair synthesis of DNA containing 8-oxoguanine in Escherichia coli | 11.3 | 9 | Citations (PDF) |
| 75 | Identification of Escherichia coli 8-oxoguanine endonuclease | 11.3 | 9 | Citations (PDF) |
| 76 | Mechanism of Regulation of 8-Hydroxyguanine Endonuclease by Oxidative Stress: Roles of FNR, ArcA, and Fur | 3.7 | 36 | Citations (PDF) |
| 77 | Induction of oh8Gua glycosylase in rat kidneys by potassium bromate (KBrO3), a renal oxidative carcinogen | 3.5 | 38 | Citations (PDF) |
| 78 | Retrosynthetic Design of Dinuclear Copper Enzymes for Azide–Alkyne Cycloaddition via Clickable Noncanonical Amino Acids | 15.0 | 2 | Citations (PDF) |
| 79 | Moyamoya Disease and the Risk of Parkinson's Disease | 3.7 | 0 | Citations (PDF) |
| 80 | Preferential Upregulation of AMOT-p80 Is Associated with YAP-Linked Resistance to 5-Fluorouracil and Oxaliplatin in Colorectal Cancer Cells | 4.2 | 0 | Citations (PDF) |
